Matches in DBpedia 2016-04 for { ?s ?p "Angela Hartley Brodie (born 28 September 1934) is a British cancer researcher who pioneered development of steroidal aromatase inhibitors. Born in Manchester in 1934, Brodie went on to study chemical pathology to a doctoral level and was awarded a fellowship sponsored by National Institutes of Health. After some time working on oral contraceptives with the Harry Brodie, whom she married, she switched focus to the effects of the estrogen-producing enzyme, aromatase, on breast cancer.Brodie managed to get an aromatase inhibitor into a limited clinical trial in London, which had such a profound effect that it led to Novartis-sponsored trials. She was behind the development of formestane, the first aromatase inhibitor used on breast cancer patients, marketed in 1994. Brodie's work has been hailed \"as among the most important contributions to cancer cure.\""@en }
Showing triples 1 to 1 of
1
with 100 triples per page.
- Angela_Hartley_Brodie abstract "Angela Hartley Brodie (born 28 September 1934) is a British cancer researcher who pioneered development of steroidal aromatase inhibitors. Born in Manchester in 1934, Brodie went on to study chemical pathology to a doctoral level and was awarded a fellowship sponsored by National Institutes of Health. After some time working on oral contraceptives with the Harry Brodie, whom she married, she switched focus to the effects of the estrogen-producing enzyme, aromatase, on breast cancer.Brodie managed to get an aromatase inhibitor into a limited clinical trial in London, which had such a profound effect that it led to Novartis-sponsored trials. She was behind the development of formestane, the first aromatase inhibitor used on breast cancer patients, marketed in 1994. Brodie's work has been hailed \"as among the most important contributions to cancer cure.\"".